Paper7694147
Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1.
Chappel JA and 1 other. Mol Biochem Parasitol, 1993. Cited by 143 papers, by iCite.
Cite this record
ConductScience Library. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1. Papers, record 7694147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7694147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antigens, Protozoan | Major topic |
| Plasmodium falciparum | Major topic |
| Protein Precursors | Major topic |
| Protozoan Proteins | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Antibodies, Protozoan | |
| Antigens, Surface | |
| Base Sequence | |
| DNA, Protozoan | |
| Epidermal Growth Factor | |
| Epitopes | |
| Escherichia coli | |
| Gene Expression | |
| Malaria Vaccines | |
| Malaria, Falciparum | |
| Merozoite Surface Protein 1 | |
| Molecular Sequence Data | |
| Recombinant Fusion Proteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MC_U117532067 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34358198 | Production and Immunogenicity of a Tag-Free Recombinant Chimera Based on PfMSP-1 and PfMSP-3 Using Alhydrogel and Dipeptide-Based Hydrogels. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34358198 | PubMed |
| 33199351 | A Chimeric Plasmodium vivax Merozoite Surface Protein Antibody Recognizes and Blocks Erythrocytic P. cynomolgi Berok Merozoites In Vitro. | Infect Immun | 2021 | https://conductscience.org/library/papers/33199351 | PubMed |
| 32348377 | Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination. | PLoS One | 2020 | https://conductscience.org/library/papers/32348377 | PubMed |
| 30558622 | Host genetic polymorphisms and serological response against malaria in a selected population in Sri Lanka. | Malar J | 2018 | https://conductscience.org/library/papers/30558622 | PubMed |
| 28993460 | Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant Pfs25, a Leading Transmission-Blocking Vaccine Candidate. | Infect Immun | 2018 | https://conductscience.org/library/papers/28993460 | PubMed |
| 26779197 | Application of a Scalable Plant Transient Gene Expression Platform for Malaria Vaccine Development. | Front Plant Sci | 2015 | https://conductscience.org/library/papers/26779197 | PubMed |
| 26246817 | Cloning and Sequence Analysis of Recombinant Plasmodium vivax Merozoite Surface Protein 1 (PvMSP-142 kDa) In pTZ57R/T Vector. | Iran J Parasitol | 2015 | https://conductscience.org/library/papers/26246817 | PubMed |
| 25652589 | Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran. | Malar J | 2015 | https://conductscience.org/library/papers/25652589 | PubMed |
| 25092910 | A conserved apicomplexan microneme protein contributes to Toxoplasma gondii invasion and virulence. | Infect Immun | 2014 | https://conductscience.org/library/papers/25092910 | PubMed |
| 24864124 | Small molecule targeting malaria merozoite surface protein-1 (MSP-1) prevents host invasion of divergent plasmodial species. | J Infect Dis | 2014 | https://conductscience.org/library/papers/24864124 | PubMed |
| 23897613 | A chimeric Plasmodium falciparum merozoite surface protein vaccine induces high titers of parasite growth inhibitory antibodies. | Infect Immun | 2013 | https://conductscience.org/library/papers/23897613 | PubMed |
| 23517907 | Anti-malarial IgG subclasses pattern and FcγRIIa (CD32) polymorphism among pregnancy-associated malaria in semi-immune Saudi women. | Malar J | 2013 | https://conductscience.org/library/papers/23517907 | PubMed |
| 22709605 | Genetic polymorphism and natural selection in the C-terminal 42 kDa region of merozoite surface protein-1 among Plasmodium vivax Korean isolates. | Malar J | 2012 | https://conductscience.org/library/papers/22709605 | PubMed |
| 22585960 | Evaluation of the immunogenicity and vaccine potential of recombinant Plasmodium falciparum merozoite surface protein 8. | Infect Immun | 2012 | https://conductscience.org/library/papers/22585960 | PubMed |
| 22392930 | Plasmodium falciparum line-dependent association of in vitro growth-inhibitory activity and risk of malaria. | Infect Immun | 2012 | https://conductscience.org/library/papers/22392930 | PubMed |
| 21292879 | Evaluation of the naturally acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil. | Am J Trop Med Hyg | 2011 | https://conductscience.org/library/papers/21292879 | PubMed |
| 20735778 | Regulated maturation of malaria merozoite surface protein-1 is essential for parasite growth. | Mol Microbiol | 2010 | https://conductscience.org/library/papers/20735778 | PubMed |
| 20713623 | New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1. | Infect Immun | 2010 | https://conductscience.org/library/papers/20713623 | PubMed |
| 20709001 | Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection. | Vaccine | 2010 | https://conductscience.org/library/papers/20709001 | PubMed |
| 20236549 | Solution structure of a Plasmodium falciparum AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria. | Malar J | 2010 | https://conductscience.org/library/papers/20236549 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7694147
GET https://conductscience.org/api/papers/v1/7694147/cited_by?page=2